Skip to main content Skip to section navigation Skip to footer
NEXGEL, Inc.
  • Home
  • About
  • Products
  • How it’s made
  • Investor relations
  • Careers
  • Contact us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Events & Presentations
    • In the News
    • Investor Presentations
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • Events & Presentations
  • In the News
  • Investor Presentations
  • Email Alerts
Dec 27, 2021 1:16pm EST

NexGel, Inc. Announces Closing of $14.2 Million Initial Public Offering

Dec 21, 2021 8:05pm EST

NexGel, Inc. Announces Listing on Nasdaq and Pricing of $14.2 Million Initial Public Offering

Nov 04, 2021 8:00am EDT

NEXGEL Announces the Launch of New MEDAGEL Migraine Relief Patch

Oct 06, 2021 8:00am EDT

NEXGEL Announces Positive Results From its Antimicrobial Study of its SilverSeal® Product Line

Sep 09, 2021 8:00am EDT

NEXGEL Announces Appointment of Miranda Toledano to Board of Directors

Sep 08, 2021 8:00am EDT

NEXGEL Announces Closing of $1.62 Million Private Placement Led by the Board of Directors

Jul 22, 2021 8:00am EDT

NEXGEL Reports Preliminary Second Quarter 2021 Financial Results and Provides Corporate Update

Jun 01, 2021 9:15am EDT

NEXGEL Appoints Adam Drapczuk as Chief Financial Officer

Mar 03, 2021 10:00am EST

NEXGEL INC. Announces the Launch of a New Global Sales Initiative

Feb 22, 2021 1:50pm EST

NEXGEL Inc. Announces OTC Release of SilverSeal(R) & Study Indications

  • arrow_back
  • 1…
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward
rss_feedNews RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
NEXGEL
2150 Cabot Blvd West
Suite B
Langhorne, PA 19047
  • Phone: 215-702-8550
  • Email: info@nexgel.com
  • Home
  • About
  • Products
  • How it’s made
  • Investor relations
  • Careers
  • Contact us
  • Terms & conditions

NEXGEL Advanced Hydrogel Solutions ©2025 NEXGEL, Inc. All Rights Reserved.